Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 3.4B | 3.3B | 2.6B |
Cost of revenue | 1.6B | 1.7B | 1.6B | 1.3B |
Gross profit | 1.6B | 1.8B | 1.6B | 1.3B |
Operating expense | ||||
Research & development | 131.1M | 124.8M | 107.4M | 110.5M |
Selling general and admin | 956.3M | 878.7M | 844.6M | 761.0M |
Other operating expenses | — | — | — | — |
Operating income | 561.9M | 770.8M | 696.3M | 421.5M |
Non operating interest income | ||||
Income | 54.6M | 33.9M | 46.2M | 23.1M |
Expense | 13.9M | 12.6M | 11.5M | 12.4M |
Other income expense | — | — | — | — |
Pretax income | 856.2M | 621.8M | 839.3M | 631.4M |
Tax provision | 176.3M | 119.9M | 217.7M | 126.5M |
Net income | 679.9M | 501.9M | 621.7M | 504.9M |
Basic EPS | — | 5.3 | 6.8 | 5.5 |
Diluted EPS | — | 5.2 | 6.6 | 5.3 |
Basic average shares | — | 92.7M | 91.2M | 91.0M |
Diluted average shares | — | 94.6M | 94.0M | 94.5M |
EBITDA | 958.5M | 719.5M | 904.7M | 728.3M |
Net income from continuing op. | 856.2M | 621.8M | 839.3M | 631.4M |
Minority interests | -8.0M | -7.0M | -4.0M | -5.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |